Services

Professional and Cost-Saving Solutions

Biocatalyst Gene Discovery & Expression

The discovery and efficient expression of biocatalyst genes form the foundation of modern biocatalysis research and industrial application. Creative Enzymes offers an integrated Biocatalyst Gene Discovery & Expression service that bridges the gap between natural genetic diversity and functional recombinant enzymes. By combining culture-independent gene discovery technologies, metagenomic screening, and host-specific codon optimization, we enable rapid identification and expression of novel and optimized biocatalysts. Our services are designed to minimize experimental uncertainty, accelerate development timelines, and deliver expression-ready gene assets suitable for downstream characterization, engineering, and scale-up. This comprehensive approach supports applications across industrial biotechnology, pharmaceutical manufacturing, green chemistry, and synthetic biology.

Background: Challenges and Opportunities in Biocatalyst Gene Discovery and Expression

Natural Genetic Diversity as the Source of Biocatalyst Innovation

Enzymes used in biocatalysis today represent only a small fraction of nature's catalytic potential. Throughout evolution, microorganisms have adapted to diverse ecological niches and chemical environments, resulting in an enormous repertoire of enzymatic activities capable of catalyzing highly specific and efficient chemical transformations. Environmental samples such as soil, marine sediments, extreme habitats, and host-associated microbiomes contain vast numbers of microorganisms that collectively encode millions of unique enzyme genes.

However, the majority of these microorganisms cannot be readily cultured under laboratory conditions. As a result, traditional culture-based screening approaches are insufficient to access the full diversity of natural biocatalysts. Modern biocatalyst discovery increasingly relies on DNA-based, culture-independent methods that enable direct exploration of genetic resources from environmental samples.

Bottlenecks in Translating Genes into Functional Biocatalysts

While advances in gene discovery technologies have dramatically expanded access to novel enzyme sequences, identifying a gene is only the first step. A major challenge lies in translating native genes into functionally expressed recombinant biocatalysts. Common bottlenecks include:

  • Poor expression levels in heterologous hosts
  • Codon bias and tRNA availability mismatches
  • Unfavorable GC content and mRNA secondary structures
  • Presence of cryptic regulatory elements or rare codons
  • Protein misfolding, aggregation, or instability

Without proper gene design and expression optimization, promising biocatalyst candidates may fail to produce sufficient soluble or active protein, limiting their practical utility.

Evolution of Integrated Gene Discovery and Expression Technologies

To overcome these challenges, modern biocatalyst development integrates gene discovery, sequence analysis, and synthetic gene engineering into a unified workflow. Metagenomics, functional screening, and bioinformatics enable the identification of novel enzyme genes, while synthetic biology tools—such as codon optimization and gene recoding—ensure efficient expression in chosen host systems.

Creative Enzymes has developed an integrated platform that connects natural biocatalyst discovery with expression-focused gene engineering, enabling clients to move efficiently from environmental DNA to expression-ready gene constructs.

Biocatalyst gene discovery and expressionFigure 1. Biocatalyst synthesis process. (Bell et al., 2021)

What We Offer: Integrated Biocatalyst Gene Discovery & Expression Services

A Modular yet Interconnected Service Portfolio

Our Biocatalyst Gene Discovery & Expression services are structured around two complementary and interdependent modules:

Service Module Description Price
Natural Biocatalyst Sampling and Screening Identification of novel enzyme genes from environmental or microbial sources using metagenomic, functional, and sequence-based screening strategies. Inquiry
Codon Optimization of Biocatalysts Host-specific gene design and recoding to maximize recombinant expression without altering amino acid sequences. Inquiry

Each module can be delivered independently or combined into a fully integrated discovery-to-expression workflow. Together, they provide a robust foundation for downstream enzyme characterization, engineering, and industrial implementation.

Service Details: From Gene Discovery to Expression-Ready Constructs

Natural Gene Discovery and Primary Screening

The first stage of biocatalyst gene discovery focuses on identifying candidate genes encoding enzymatic activities of interest. Depending on project goals, Creative Enzymes designs customized discovery strategies that may include:

  • Environmental sample selection and sourcing
  • Metagenomic DNA extraction and library construction
  • Functional screening for target catalytic activities
  • Sequence-based screening using bioinformatics and homology searches

Functional metagenomics enables direct identification of enzyme activity without prior sequence knowledge, while sequence-based approaches leverage conserved motifs and known enzyme families to efficiently mine genetic datasets. High-throughput screening platforms allow rapid evaluation of large numbers of candidates.

Outcome: A curated set of promising biocatalyst gene candidates with validated or predicted activity.

Gene Sequence Analysis and Expression Feasibility Assessment

Once candidate genes are identified, their native sequences are evaluated for compatibility with heterologous expression systems. This assessment includes:

  • Codon usage analysis relative to target host organisms
  • GC content distribution and sequence complexity evaluation
  • Identification of inhibitory sequence motifs or rare codon clusters
  • Prediction of mRNA secondary structures affecting translation

This stage provides an early assessment of expression risk and informs the design of optimization strategies before experimental expression efforts begin.

Outcome: Clear guidance on whether native genes are suitable for direct expression or require optimization.

Codon Optimization and Synthetic Gene Design

Codon optimization is a critical step in transforming native biocatalyst genes into expression-ready constructs. Creative Enzymes performs comprehensive gene recoding while preserving the original amino acid sequence. Optimization strategies include:

  • Alignment with host-specific codon bias and tRNA abundance
  • Balancing GC content to enhance transcriptional and translational efficiency
  • Minimization of mRNA secondary structures near ribosome binding regions
  • Removal of cryptic splice sites, premature terminators, or repetitive elements

Synthetic gene designs are tailored to specific expression hosts, including bacteria, yeast, fungi, insect, and mammalian systems.

Outcome: Optimized gene sequences suitable for DNA synthesis and efficient recombinant expression.

Integration with Downstream Expression and Characterization

Our gene discovery and optimization services are designed to integrate seamlessly with downstream biocatalysis workflows. Optimized gene constructs can be directly transferred into:

  • Enzyme expression and production services
  • Biocatalyst characterization and kinetic analysis
  • Mechanistic modeling and rational engineering programs

This continuity ensures that early-stage gene discovery decisions support long-term development goals, from laboratory research to industrial-scale application.

Service Workflow

Workflow of biocatalyst gene discovery and expression service

Contact Our Team

Why Choose Us: Advantages of Our Gene Discovery & Expression Platform

End-to-End Coverage from Nature to Expression

We bridge the gap between environmental genetic diversity and functional recombinant biocatalysts within a single service framework.

Advanced Metagenomic and Synthetic Biology Expertise

Our team integrates metagenomics, bioinformatics, and gene engineering technologies to maximize discovery success.

Host-Specific, Data-Driven Design

Gene optimization strategies are tailored to the biological constraints of real expression systems.

Reduced Experimental Trial-and-Error

Early computational assessment and optimization minimize costly experimental failures.

Scalable for Research and Industrial Projects

Our platform supports both small-scale discovery projects and large enzyme screening campaigns.

Seamless Integration with Downstream Biocatalysis Services

Optimized genes are immediately compatible with characterization, engineering, and production workflows.

Case Studies: Biocatalyst Gene Discovery & Expression in Practice

Case 1: Discovery of Novel Carboxylesterases via Metagenomic Screening

Metagenomic screening enables access to vast global biochemical diversity. In this study, over one million clones from sixteen environmental DNA libraries were screened for carboxylesterase activity, yielding 714 positive hits. Eighty selected genes, spanning 17 protein families—including previously uncharacterized and cyclase-like proteins—were validated. Notably, three enzymes exhibited lipase activity, and seven showed polyester depolymerization against polylactic acid and polycaprolactone. Biochemical characterization revealed substrate preferences, while site-directed mutagenesis identified key catalytic residues. Structural analysis of MGS0169, a metal-dependent esterase, uncovered a novel active site. This work highlights metagenomics as a powerful, activity-centered approach to uncover diverse and previously unpredictable biocatalysts.

Activity screening of environmental metagenomic libraries reveals novel carboxylesterase familiesFigure 2. Agar-based screening of metagenomic libraries and purified metagenomic proteins for esterase and lipase activities. (Popovic et al., 2017)

Case 2: Enhancing Heterologous Enzyme Expression via 3'UTR Engineering

3'-Untranslated region (3'UTR) engineering was applied to improve soluble expression of heterologous proteins, including Baeyer-Villiger monooxygenases (BVMOs), in Escherichia coli. By inserting gene fragments containing putative RNase E recognition sites into the 3'UTR, mRNA levels were modulated, resulting in significantly increased soluble protein amounts. This directly translated into higher in vivo catalytic activities, which correlated with the number of RNase E cleavage sites. For example, BVMO BmoF1 from Pseudomonas fluorescens showed linear enhancement in biotransformation activity with increasing cleavage sites. This study demonstrates that 3'UTR engineering is a powerful tool to optimize enzyme solubility and fine-tune biocatalytic activity in microbial hosts.

Effect of 3′UTRCAT on expression of the bmoF1Figure 3. Effect of 3'UTR engineering on BmoF1 expression in E. coli. (A) Relative mRNA levels of BmoF1 with native and CAT-variant 3'UTRs, normalized to ihfB. (B) SDS-PAGE and Western blot of soluble protein fractions. (C) SDS-PAGE of insoluble protein fractions. Lanes correspond to native 3'UTR and CAT variants (257, 357, 557, 657). (Song et al., 2016)

FAQs: Frequently Asked Questions About Biocatalyst Gene Discovery & Expression

  • Q: What types of biocatalysts can be discovered using this service?

    A: Our platforms enable the discovery of a wide range of enzymatic classes, including oxidoreductases, hydrolases, transferases, lyases, and isomerases. This includes enzymes from both common and extremophilic organisms, as well as entirely novel biocatalysts with unique substrate specificities.
  • Q: Do I need prior knowledge of the gene sequence?

    A: No. Functional metagenomic approaches allow the identification of enzymes solely based on catalytic activity, without any prior sequence information. For known sequences, we can perform targeted codon optimization to enhance expression.
  • Q: Can gene discovery and codon optimization be ordered separately?

    A: Yes. Each service module—gene discovery or codon optimization—can be requested independently. Alternatively, they can be integrated into a streamlined workflow for rapid identification and high-yield expression of target biocatalysts.
  • Q: Which expression hosts are supported?

    A: We support a broad spectrum of hosts, including bacterial (e.g., E. coli), yeast (e.g., Pichia pastoris), filamentous fungi, insect cell lines, and mammalian systems. Host selection can be tailored to the desired application, protein folding requirements, and post-translational modifications.
  • Q: How does this service support downstream enzyme engineering?

    A: Optimized and well-characterized gene constructs provide a reliable foundation for further studies, including enzymatic characterization, rational or directed mutagenesis, pathway engineering, and large-scale process development. This ensures faster and more predictable results in downstream applications.
  • Q: What deliverables will I receive?

    A: Clients receive fully curated gene sequences, codon-optimized constructs, and comprehensive technical reports detailing discovery methods, optimization rationale, predicted expression efficiency, and recommendations for expression and downstream processing. Optional guidance on enzyme characterization and integration into production systems can also be provided.
  • Q: How scalable is the workflow for high-throughput projects?

    A: Our service can accommodate both small-scale, single-target projects and large-scale libraries involving tens of thousands of environmental clones or gene variants, supported by high-throughput screening and automated data analysis platforms.
  • Q: Can the discovered or optimized genes be used for industrial applications?

    A: Absolutely. Genes are designed for expression in hosts suitable for industrial processes, with attention to enzyme stability, solubility, and catalytic efficiency to ensure practical applicability in biotechnology, biopharmaceuticals, and green chemistry.
  • Q: How long does a typical project take?

    A: Project timelines vary depending on the scope and complexity. Gene discovery from environmental samples typically takes several weeks for library construction and screening, while codon optimization and synthesis can often be completed in a few weeks. Integrated workflows are carefully scheduled to minimize turnaround time while maintaining high-quality outputs.

References:

  1. Bell EL, Finnigan W, France SP, et al. Biocatalysis. Nat Rev Methods Primers. 2021;1(1):46. doi:10.1038/s43586-021-00044-z
  2. Popovic A, Hai T, Tchigvintsev A, et al. Activity screening of environmental metagenomic libraries reveals novel carboxylesterase families. Sci Rep. 2017;7(1):44103. doi:10.1038/srep44103
  3. Song JW, Woo JM, Jung GY, Bornscheuer UT, Park JB. 3'-UTR engineering to improve soluble expression and fine-tuning of activity of cascade enzymes in Escherichia coli. Sci Rep. 2016;6(1):29406. doi:10.1038/srep29406

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.

Services
Online Inquiry

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.